Locally unlocks prodrugs by radiopharmaceutical in tumor for cancer therapy
Changlun Wang(Peking University), Zhibo Liu(Beijing National Laboratory for Molecular Sciences), Zexuan Ding, Xi‐Yang Cui(Chinese Academy of Medical Sciences & Peking Union Medical College), Junyi Chen(Peking University), Zihang Zhang(China Aerospace Science and Industry Corporation (China)), Siyong Shen(Peking University), Senhai Zeng(Peking University), Mengxin Xu(Peking University)
Cited by 16
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
A corrosion-resistant RuMoNi catalyst for efficient and long-lasting seawater oxidation and anion exchange membrane electrolyzer
|Nature Communications|2023|483
Covalent targeted radioligands potentiate radionuclide therapy
|Nature|2024|165
A highly active and durable electrocatalyst for large current density hydrogen evolution reaction
|Science Bulletin|2019|84